APA (7th ed.) Citation

Sullivan, R., Hou, J., Yu, L., Wilk, B., Sykes, J., Biernaski, H., . . . Dhanvantari, S. (2024). Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction. Journal of Nuclear Medicine, 65(10), 1633. https://doi.org/10.2967/jnumed.124.267578

Chicago Style (17th ed.) Citation

Sullivan, Rebecca, et al. "Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction." Journal of Nuclear Medicine 65, no. 10 (2024): 1633. https://doi.org/10.2967/jnumed.124.267578.

MLA (9th ed.) Citation

Sullivan, Rebecca, et al. "Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction." Journal of Nuclear Medicine, vol. 65, no. 10, 2024, p. 1633, https://doi.org/10.2967/jnumed.124.267578.